Super-Chevy454
kiwifarms.net
- Joined
- Apr 2, 2018
Take this news with a pinch of salt but if it's true, I think karma will bite back Pfizer.
It looks like Pfizer might be anticipating some very bad news.
They quietly added a language warning that “Unfavorable Pre-Clinical, Clinical Or Safety Data” may impact business.
From Zero Hedge:
Now, Pfizer – which just forecast $54 billion in Covid-related sales in 2022, appears to be anticipating some bad news, as evidenced by several redline changes in their Q4 earnings releases.
As Rubicon Capital’s Kelly Brown notes on Twitter, the changes center around disclosures of unfavorable safety data.
For example, in Q4 they added: “or further information regarding the quality of pre-clinical, clinical or safety data, including by audit or inspection.”